得克萨斯州A&M开发的单一注射刺激了ANP在心脏病发作后改善心脏恢复,提供了非侵入性的长期保护。 A Texas A&M-developed single injection boosts ANP to improve heart recovery after a heart attack, offering non-invasive, long-lasting protection.

使用自我强化的RNA技术进行新的单次注射,可以提高自然激素ANP的水平,减少压力和伤疤,从而在心脏病发作后改善心脏恢复。 A new single injection using self-amplifying RNA technology may improve heart recovery after a heart attack by boosting levels of the natural hormone ANP, which reduces stress and scarring. 由得克萨斯州A&M研究人员开发的治疗促使骨骼肌肉在几周内仅用一剂剂量生产ANP,在关键恢复期间提供持续保护。 Developed by Texas A&M researchers, the treatment prompts skeletal muscle to produce ANP for weeks with just one dose, offering sustained protection during critical recovery. 与以往的侵入性方法不同,这种非侵入性方法增强了身体的自然愈合过程,可以防止长期损害。 Unlike previous invasive methods, this non-invasive approach enhances the body’s natural healing process and could prevent long-term damage. 人类的试验尚待进行,但治疗显示有希望广泛、方便地使用。 Human trials are pending, but the therapy shows promise for widespread, accessible use.